%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/17425255.2020.1828344
en
An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs)
Fabio Facchinetti
Pietro Cavalli
Andrew J. Copp
Rosario D’Anna
Eleni Kandaraki
Nicholas D.E. Greene
Vittorio Unfer
Taylor & Francis
Expert Opinion on Drug Metabolism & Toxicology, doi:10.1080/17425255.2020.1828344
D-chiro-inositol (DCI)
gestational diabetes mellitus (GDM)
insulin resistance
myo-inositol (MI)
neural tube defects (NTDs)
prevention
Journal
Expert Opinion on Drug Metabolism & Toxicology
© 2020 Informa UK Limited, trading as Taylor & Francis Group
0
0
10.1080/17425255.2020.1828344
https://doi.org/10.1080/17425255.2020.1828344
VoR
2020-09-23T22:56:13+05:30
PScript5.dll Version 5.2.2
2020-10-04T07:40:01-07:00
2020-10-04T07:40:01-07:00
D-chiro-inositol (DCI); gestational diabetes mellitus (GDM); insulin resistance; myo-inositol (MI); neural tube defects (NTDs); prevention
iText 4.2.0 by 1T3XT
uuid:95346975-d7f0-45d2-9edc-48c14521b7dc
uuid:2da8c34f-bf92-44a7-aef3-05fdf0ef371c
2020-09-23truewww.tandfonline.com10.1080/17425255.2020.1828344www.tandfonline.comtrue2020-09-2310.1080/17425255.2020.1828344
endstream
endobj
4 0 obj
<>stream
xYK$
?Tz Ars2@OI< K~HXم{YjZH/ o%q..9&,.=Zײ.\
ey{_~= ^/t,.4o4"rixQ$w=U)fNy}5ksh0OF-\ADP"_Yt]I%
}*rT:UUAu&it^pyQuѷZbVMd®{]uNP䐋y֚EP~-~Oo8q;WZ
#.pΏy_]ɕGat+-`